11/14
12:20 pm
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Low
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
11/14
09:08 am
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Avoro Capital Advisors LLC
Low
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Avoro Capital Advisors LLC
11/12
04:13 pm
glue
Form SCHEDULE 13D/A Monte Rosa Therapeutics, Filed by: Versant Venture Capital VI, L.P.
Low
Report
Form SCHEDULE 13D/A Monte Rosa Therapeutics, Filed by: Versant Venture Capital VI, L.P.
11/6
07:05 am
glue
Form 10-Q Monte Rosa Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Monte Rosa Therapeutics, For: Sep 30
11/6
07:03 am
glue
Form 8-K Monte Rosa Therapeutics, For: Nov 06
Medium
Report
Form 8-K Monte Rosa Therapeutics, For: Nov 06
10/31
11:04 am
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: VANGUARD GROUP INC
10/17
04:29 pm
glue
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: TCG Crossover GP II, LLC
Low
Report
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: TCG Crossover GP II, LLC
10/3
12:19 pm
glue
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: Dimension Capital I, L.P.
Low
Report
Form SCHEDULE 13G Monte Rosa Therapeutics, Filed by: Dimension Capital I, L.P.
9/15
07:01 am
glue
Form 8-K Monte Rosa Therapeutics, For: Sep 15
High
Report
Form 8-K Monte Rosa Therapeutics, For: Sep 15